Skip to content

Clinical trials

Terminated Phase 2 trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2 Status: Terminated Country / region: Hong Kong Clear all

55 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20073
20081
20093
20102
20114
20126
20134
20145
20151
20161
20171
20183
20193
20206
20215
20224
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated55

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals8
Pfizer5
Gilead Sciences4
Amgen3
Assembly Biosciences3
GlaxoSmithKline3
AstraZeneca2
Bayer2
Biogen2
Chinese University of Hong Kong2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B, Chronic7
Carcinoma, Non-Small-Cell Lung6
Breast Neoplasms4
Lupus Nephritis4
Carcinoma, Hepatocellular3
Hepatitis B3
Lupus Erythematosus, Systemic3
Arthritis, Rheumatoid2
Asthma2
Colorectal Neoplasms2

Trials

Showing 1 to 25 of 55. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.